Kangzhe Pharmaceutical (00867) announced interim results. Profit attributable to company owners increased 4.77% year over year to 986 million yuan

According to the Zhitong Finance App, Kangzhe Pharmaceutical (00867) announced its 2026 interim results. The turnover increased 12.5% year on year to about 4.5 billion yuan, gross profit increased 11.4% year on year to about 3.21 billion yuan, profit for the period increased 4.3% year on year to 971.5 billion yuan, profit attributable to company owners increased 4.77% year on year to 986 million yuan, basic profit per share, and an interim dividend of 0.1634 yuan per share.

In the first half of 2026, the phased results of Kangzhe Pharmaceutical's growth engine switching were further demonstrated: revenue from products related to Guocai (included in national centralized volume procurement) was basically stabilized, and innovative drugs and exclusive drugs were an important driving force for the Group's growth, driving steady growth in the Group's turnover and period profit; of these, innovative and exclusive products achieved a total revenue of 1,698.7 billion yuan, an increase of 19.7% over the previous year, accounting for 37.7% of the turnover (the same period last year was 1,419 billion yuan, accounting for 35.5%). The ratio increased to 32.0% (1,419 billion yuan in the same period last year, accounting for 30.4%). Innovative results continue to transform: 3 innovative drugs have been approved for marketing, 5 innovative drugs (including 6 indications) are under review, 3 self-developed products (including 5 indications) have been approved for clinical trial (IND), and 1 new cooperative project has been added. The cooperative products are 1 innovative intravenous iron agent and 1 original intravenous iron agent that has already been marketed in China. The innovative pipeline and product portfolio are progressing according to plan. At the same time, the Group's specialty scale advantage has been further consolidated, and product registration and commercialization verification for the internationalization of the industry continue to make progress, laying a more solid foundation for high-quality and sustainable growth.